PTAB statistics

PTAB Trial Statistics as of July 31, 2015

As of July 31, 2015, USPTO records show 3,663 AIA trial petitions filed since September 16, 2012 (3,277 IPR, 368 CBM, 10 PGR, 8 derivation). The Board had instituted trial on 1,690 petitions and denied 1,042 (61.9% instituted) and had issued 532 final written decisions. In fiscal year 2015 to that date, 1,582 petitions were filed.

Key Facts

As of
July 31, 2015
Fiscal year
FY2015
Petitions filed (cumulative)
3,663
Institution rate (cumulative)
61.9%
Petitions filed (FY2015 to date)
1,582
Data retrieved
October 31, 2026
On this page
  1. Cumulative Figures as of July 31, 2015
  2. Fiscal Year 2015 to Date
  3. Change Since June 30, 2015
  4. Trial Types Covered
  5. How These Figures Were Compiled
  6. Related Statistics

This page gives Patent Trial and Appeal Board trial figures as of July 31, 2015, which falls in fiscal year 2015 (October 1, 2014 to September 30, 2015). The cumulative figures run from September 16, 2012, when AIA trials began. The full year is covered on the FY2015 statistics page.

Cumulative Figures as of July 31, 2015

Events from September 16, 2012 to July 31, 2015, by trial type:

MeasureIPRPGRCBMDERTotal
Petitions filed3,2771036883,663
Institution decisions: instituted1,496219201,690
Institution decisions: denied936210131,042
Institution rate (by petition)61.5%50.0%65.5%0.0%61.9%
Final written decisions4740580532
Terminations without a final written decisionCount
Settlements385
Adverse judgment0
Dismissed0
Other terminations30

Fiscal Year 2015 to Date

Events from October 1, 2014 to July 31, 2015:

MeasureIPRPGRCBMDERTotal
Petitions filed1,436813531,582
Institution decisions: instituted7572850844
Institution decisions: denied5832450630
Institution rate (by petition)56.5%50.0%65.4%—57.3%
Final written decisions3240410365
Terminations without a final written decisionCount
Settlements241
Adverse judgment0
Dismissed0
Other terminations22

Change Since June 30, 2015

Between the previous dated page (June 30, 2015) and July 31, 2015, 123 petitions were filed, 84 trials were instituted, 89 petitions were denied institution and 35 final written decisions issued. The cumulative institution rate moved from 62.8% to 61.9%.

Trial Types Covered

3,277 of the 3,663 petitions (89.5%) were for inter partes review, which challenges patent claims on prior-art grounds under 35 U.S.C. chapter 31. The remainder were for covered business method review (368), post-grant review under chapter 32 (10) and derivation proceedings (8). Institution standards differ by proceeding; see the threshold standards.

How These Figures Were Compiled

The figures are counted from USPTO Open Data Portal records retrieved on October 31, 2026, keeping only events dated on or before July 31, 2015: a petition by its filing date, an institution decision by its decision date, and a final written decision or termination by its date. They are a reconstruction from the current records, not the USPTO’s report of that date, and may differ from statistics the USPTO published at the time. Final written decision outcomes are not reported because the records state them for too few decisions. The methodology gives the counting rules in full.

Frequently Asked Questions

How many AIA trial petitions had been filed as of July 31, 2015?

USPTO records show 3,663 petitions filed from September 16, 2012 to July 31, 2015: 3,277 IPR, 368 CBM, 10 PGR and 8 derivation.

What was the PTAB institution rate as of July 31, 2015?

Cumulatively, 61.9% by petition: 1,690 instituted and 1,042 denied. In FY2015 to that date the rate was 57.3%.

Primary Sources

  1. USPTO Open Data Portal (PTAB trial proceedings and decisions data)
  2. USPTO Patent Trial and Appeal Board statistics
  3. 35 U.S.C. chapter 31 (inter partes review)
  4. 35 U.S.C. chapter 32 (post-grant review)
  5. 37 C.F.R. Part 42 (trial practice before the PTAB)

Educational information; not legal advice. Statutes, rules and USPTO practice change. Confirm against the primary sources and consult a registered patent practitioner before acting. Disclaimer.